235 related articles for article (PubMed ID: 8650244)
41. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
[TBL] [Abstract][Full Text] [Related]
42. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
[TBL] [Abstract][Full Text] [Related]
43. Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts.
Xie H; Rachakonda PS; Heidenreich B; Nagore E; Sucker A; Hemminki K; Schadendorf D; Kumar R
Oncotarget; 2016 Mar; 7(13):16490-504. PubMed ID: 26909863
[TBL] [Abstract][Full Text] [Related]
44. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
Subhi AL; Tang B; Balsara BR; Altomare DA; Testa JR; Cooper HS; Hoffman JP; Meropol NJ; Kruger WD
Clin Cancer Res; 2004 Nov; 10(21):7290-6. PubMed ID: 15534104
[TBL] [Abstract][Full Text] [Related]
45. Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids.
Porterfield BW; Olopade OI; Rowley JD; Diaz MO
Somat Cell Mol Genet; 1994 Sep; 20(5):391-400. PubMed ID: 7825061
[TBL] [Abstract][Full Text] [Related]
46. Codeletion of p15 and p16 in primary malignant mesothelioma.
Xio S; Li D; Vijg J; Sugarbaker DJ; Corson JM; Fletcher JA
Oncogene; 1995 Aug; 11(3):511-5. PubMed ID: 7630635
[TBL] [Abstract][Full Text] [Related]
47. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity.
Gordon RB; Blackwell K; Emmerson BT
Biochim Biophys Acta; 1987 Jan; 927(1):1-7. PubMed ID: 3098299
[TBL] [Abstract][Full Text] [Related]
49. P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9.
Faienza MF; della Ragione F; Basso G; Coppola B; Miraglia del Giudice E; Schettini F; Iolascon A
Br J Haematol; 1996 Jun; 93(3):632-6. PubMed ID: 8652384
[TBL] [Abstract][Full Text] [Related]
50. Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma patients.
Miyazaki S; Nishioka J; Shiraishi T; Matsumine A; Uchida A; Nobori T
Int J Oncol; 2007 Nov; 31(5):1069-76. PubMed ID: 17912432
[TBL] [Abstract][Full Text] [Related]
51. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.
Diaz MO; Ziemin S; Le Beau MM; Pitha P; Smith SD; Chilcote RR; Rowley JD
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5259-63. PubMed ID: 3134658
[TBL] [Abstract][Full Text] [Related]
52. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
Nakanishi H; Wang XL; Imai FL; Kato J; Shiiba M; Miya T; Imai Y; Tanzawa H
Anticancer Res; 1999; 19(1A):29-34. PubMed ID: 10226521
[TBL] [Abstract][Full Text] [Related]
53. Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma.
Jagasia AA; Block JA; Diaz MO; Nobori T; Gitelis S; Inerot SE; Iyer AP
Cancer Lett; 1996 Jul; 105(1):77-90. PubMed ID: 8689636
[TBL] [Abstract][Full Text] [Related]
54. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
55. Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.
Li CF; Fang FM; Kung HJ; Chen LT; Wang JW; Tsai JW; Yu SC; Wang YH; Li SH; Huang HY
Oncotarget; 2014 Nov; 5(22):11428-41. PubMed ID: 25426549
[TBL] [Abstract][Full Text] [Related]
56. Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies.
Bertino JR; Waud WR; Parker WB; Lubin M
Cancer Biol Ther; 2011 Apr; 11(7):627-32. PubMed ID: 21301207
[TBL] [Abstract][Full Text] [Related]
57. Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
Collins CC; Volik SV; Lapuk AV; Wang Y; Gout PW; Wu C; Xue H; Cheng H; Haegert A; Bell RH; Brahmbhatt S; Anderson S; Fazli L; Hurtado-Coll A; Rubin MA; Demichelis F; Beltran H; Hirst M; Marra M; Maher CA; Chinnaiyan AM; Gleave M; Bertino JR; Lubin M; Wang Y
Mol Cancer Ther; 2012 Mar; 11(3):775-83. PubMed ID: 22252602
[TBL] [Abstract][Full Text] [Related]
58. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
59. The structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase at 1.7 A resolution provides insights into substrate binding and catalysis.
Appleby TC; Erion MD; Ealick SE
Structure; 1999 Jun; 7(6):629-41. PubMed ID: 10404592
[TBL] [Abstract][Full Text] [Related]
60. Methylthioadenosine phosphorylase expression in cutaneous squamous cell carcinoma.
Alhebshi HM; Pant I; Kaur G; Hashim H; Mabruk MJ
Asian Pac J Cancer Prev; 2008; 9(2):291-4. PubMed ID: 18712977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
